Table 2.

Shared decision making, report of results to patients, and time allocation, as a result of actionable PGx recommendations (n = 92).

Shared Decision Making
Did you discuss the pharmacogenomic recommendation with the treating physician?
Yes	77.2%
No	18.5%
Missing	4.3%
Do you agree to the final treatment decision/change that was made based on your PGx-guided recommendation?
Yes	82.6%
No	2.2%
Missing	15.2%
Why do you disagree? (n = 2) “I would have preferred to alter the drug but the patient had already initiated it and therefore I preferred not to alter it”; “The patient was already set on a dose of metoprolol and therefore I preferred not adjusting it”
Report of results to the patient
Who discussed the results of the PGx recommendation with the patient?
Pharmacist	56.5%
Pharmacy technician	3.3%
Treating physician	15.2%
Result was to be reported at the time of interview	20.7%
Missing	4.4%
Time allocation
Approximately how much time did you spend on handling this recommendation?
Mean number of minutes (SD)	18.6 (13.1)
Range	3–90
Missing	10

Abbreviations used: SD = standard deviation, ADEs = adverse drug events.